She adds there's also been a significant change order that expands its involvement in a phase III clinical trial for Huntington's disease worth an additional £900,000.
Investor deep dive
IXICO's strong order book and rising revenues underline growing market presence in brain data analysis
Full interview: IXICO PLC lands two new clients as it continues to expand portfolio
Quick facts: IXICO PLC
Market Cap: £19.86 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE